Selected research
Industry Research
Trastuzumab Injection Industry Research Report 2026
Market perspective
The global Trastuzumab Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Trastuzumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Trastuzumab Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Trastuzumab Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Trastuzumab Injection include Celltrion, Glenmark, Samsung Bioepsis, AstraZeneca, Amgen, Shanghai Henlius Biotech, Hisun Biopharmaceutical, Pfizer and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Trastuzumab Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Trastuzumab Injection Market by Company
Celltrion
Glenmark
Samsung Bioepsis
AstraZeneca
Amgen
Shanghai Henlius Biotech
Hisun Biopharmaceutical
Pfizer
Roche
Mylan
Remegen Co., Ltd.
Trastuzumab Injection Segment by Type
60 mg
440 mg
150 mg
Others
Trastuzumab Injection Segment by Application
Hospitals
Clinics
Others
Trastuzumab Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Trastuzumab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Trastuzumab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Trastuzumab Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Trastuzumab Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Trastuzumab Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Trastuzumab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 60 mg
- 440 mg
- 150 mg
- Others
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Celltrion
- Glenmark
- Samsung Bioepsis
- AstraZeneca
- Amgen
- Shanghai Henlius Biotech
- Hisun Biopharmaceutical
- Pfizer
- Roche
- Mylan
- Remegen Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Trastuzumab Injection Market Size (2021-2032)
- 2.2.2 Global Trastuzumab Injection Sales (2021-2032)
- 2.2.3 Global Trastuzumab Injection Market Average Price (2021-2032)
- 2.3 Trastuzumab Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 60 mg
- 2.3.3 440 mg
- 2.3.4 150 mg
- 2.3.5 Others
- 2.4 Trastuzumab Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Trastuzumab Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Trastuzumab Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Trastuzumab Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Trastuzumab Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Trastuzumab Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Trastuzumab Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Trastuzumab Injection, Product Type & Application
- 3.8 Global Manufacturers of Trastuzumab Injection, Established Date
- 3.9 Global Trastuzumab Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Celltrion
- 4.1.1 Celltrion Company Information
- 4.1.2 Celltrion Business Overview
- 4.1.3 Celltrion Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Celltrion Trastuzumab Injection Product Portfolio
- 4.1.5 Celltrion Recent Developments
- 4.2 Glenmark
- 4.2.1 Glenmark Company Information
- 4.2.2 Glenmark Business Overview
- 4.2.3 Glenmark Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Glenmark Trastuzumab Injection Product Portfolio
- 4.2.5 Glenmark Recent Developments
- 4.3 Samsung Bioepsis
- 4.3.1 Samsung Bioepsis Company Information
- 4.3.2 Samsung Bioepsis Business Overview
- 4.3.3 Samsung Bioepsis Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Samsung Bioepsis Trastuzumab Injection Product Portfolio
- 4.3.5 Samsung Bioepsis Recent Developments
- 4.4 AstraZeneca
- 4.4.1 AstraZeneca Company Information
- 4.4.2 AstraZeneca Business Overview
- 4.4.3 AstraZeneca Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AstraZeneca Trastuzumab Injection Product Portfolio
- 4.4.5 AstraZeneca Recent Developments
- 4.5 Amgen
- 4.5.1 Amgen Company Information
- 4.5.2 Amgen Business Overview
- 4.5.3 Amgen Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Amgen Trastuzumab Injection Product Portfolio
- 4.5.5 Amgen Recent Developments
- 4.6 Shanghai Henlius Biotech
- 4.6.1 Shanghai Henlius Biotech Company Information
- 4.6.2 Shanghai Henlius Biotech Business Overview
- 4.6.3 Shanghai Henlius Biotech Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shanghai Henlius Biotech Trastuzumab Injection Product Portfolio
- 4.6.5 Shanghai Henlius Biotech Recent Developments
- 4.7 Hisun Biopharmaceutical
- 4.7.1 Hisun Biopharmaceutical Company Information
- 4.7.2 Hisun Biopharmaceutical Business Overview
- 4.7.3 Hisun Biopharmaceutical Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hisun Biopharmaceutical Trastuzumab Injection Product Portfolio
- 4.7.5 Hisun Biopharmaceutical Recent Developments
- 4.8 Pfizer
- 4.8.1 Pfizer Company Information
- 4.8.2 Pfizer Business Overview
- 4.8.3 Pfizer Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer Trastuzumab Injection Product Portfolio
- 4.8.5 Pfizer Recent Developments
- 4.9 Roche
- 4.9.1 Roche Company Information
- 4.9.2 Roche Business Overview
- 4.9.3 Roche Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Roche Trastuzumab Injection Product Portfolio
- 4.9.5 Roche Recent Developments
- 4.10 Mylan
- 4.10.1 Mylan Company Information
- 4.10.2 Mylan Business Overview
- 4.10.3 Mylan Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mylan Trastuzumab Injection Product Portfolio
- 4.10.5 Mylan Recent Developments
- 4.11 Remegen Co., Ltd.
- 4.11.1 Remegen Co., Ltd. Company Information
- 4.11.2 Remegen Co., Ltd. Business Overview
- 4.11.3 Remegen Co., Ltd. Trastuzumab Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Remegen Co., Ltd. Trastuzumab Injection Product Portfolio
- 4.11.5 Remegen Co., Ltd. Recent Developments
5 Global Trastuzumab Injection Market Scenario by Region
- 5.1 Global Trastuzumab Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Trastuzumab Injection Sales by Region: 2021-2032
- 5.2.1 Global Trastuzumab Injection Sales by Region: 2021-2026
- 5.2.2 Global Trastuzumab Injection Sales by Region: 2027-2032
- 5.3 Global Trastuzumab Injection Revenue by Region: 2021-2032
- 5.3.1 Global Trastuzumab Injection Revenue by Region: 2021-2026
- 5.3.2 Global Trastuzumab Injection Revenue by Region: 2027-2032
- 5.4 North America Trastuzumab Injection Market Facts & Figures by Country
- 5.4.1 North America Trastuzumab Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Trastuzumab Injection Sales by Country (2021-2032)
- 5.4.3 North America Trastuzumab Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Trastuzumab Injection Market Facts & Figures by Country
- 5.5.1 Europe Trastuzumab Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Trastuzumab Injection Sales by Country (2021-2032)
- 5.5.3 Europe Trastuzumab Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Trastuzumab Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Trastuzumab Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Trastuzumab Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Trastuzumab Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Trastuzumab Injection Market Facts & Figures by Country
- 5.7.1 South America Trastuzumab Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Trastuzumab Injection Sales by Country (2021-2032)
- 5.7.3 South America Trastuzumab Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Trastuzumab Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Trastuzumab Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Trastuzumab Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Trastuzumab Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Trastuzumab Injection Sales by Type (2021-2032)
- 6.1.1 Global Trastuzumab Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Trastuzumab Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Trastuzumab Injection Revenue by Type (2021-2032)
- 6.2.1 Global Trastuzumab Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Trastuzumab Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Trastuzumab Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Trastuzumab Injection Sales by Application (2021-2032)
- 7.1.1 Global Trastuzumab Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Trastuzumab Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Trastuzumab Injection Revenue by Application (2021-2032)
- 7.2.1 Global Trastuzumab Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Trastuzumab Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Trastuzumab Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Trastuzumab Injection Value Chain Analysis
- 8.1.1 Trastuzumab Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Trastuzumab Injection Production Mode & Process
- 8.2 Trastuzumab Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Trastuzumab Injection Distributors
- 8.2.3 Trastuzumab Injection Customers
9 Global Trastuzumab Injection Analyzing Market Dynamics
- 9.1 Trastuzumab Injection Industry Trends
- 9.2 Trastuzumab Injection Industry Drivers
- 9.3 Trastuzumab Injection Industry Opportunities and Challenges
- 9.4 Trastuzumab Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst